United States Diagnostics & Research news

05:12 29 Jul 2026

TradingKey Market update Main company 🇺🇸 United States

Fulgent Genetics Inc (FLGT) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Fulgent Genetics Inc (FLGT), noting its score of 6.80, which ranks 25 out of 75 in the Healthcare Providers & Services industry. The company's beta of 0.93 indicates it tends to underperform in up markets but decline …

FLGT main company

Sharemaestro market context Price above Trend Line 52 weeks -14.7% · Next-week setup negative 42.1%

05:11 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

IMUX|Immunic Inc|Price:13.271|Chg%:-0.539

This article provides a detailed stock analysis of Immunic Inc (IMUX) based on TradingKey's comprehensive stock score. It highlights Immunic's strong fundamentals and high growth potential, noting it's fairly valued within the Biotechnology & Medical Research industry. The analysis also covers high institutional ownership …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

04:41 29 Jul 2026

TradingKey Market update Main company 🇺🇸 United States

Veracyte Inc (VCYT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Veracyte Inc (VCYT), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. The analysis suggests VCYT is suitable for range-bound swing trading, with indicators showing mixed signals …

VCYT main company

Sharemaestro market context Trend signal active 52 weeks +33.1%

04:40 29 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Myriad Genetics (MYGN) Reports Q2: Everything You Need To Know Ahead Of Earnings

Myriad Genetics (MYGN) is set to report Q2 earnings this Thursday, with analysts expecting a 2.5% year-on-year revenue decline. The company missed revenue expectations last quarter, and its stock is down 9.5% over the last month, contrasting with a 4.4% average rise in the …

MYGN main company

Sharemaestro market context Price below Trend Line 52 weeks -49.7%

04:39 29 Jul 2026

Investing.com Analyst action Provider-linked mention 🇺🇸 United States

Why is Solventum stock surging today?

Solventum stock surged over 7% today after UBS upgraded the healthcare company from Neutral to Buy, setting a price target of $95. This upgrade, combined with supportive analyst sentiment and an upcoming Q2 2026 earnings report on August 5, pushed Solventum shares towards their …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

04:14 29 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

What To Expect From Labcorp’s (LH) Q2 Earnings

Labcorp (LH) is set to announce its Q2 earnings this Thursday. Analysts expect a 5.3% year-on-year revenue growth, a slowdown from the previous year, though the company generally met revenue expectations last quarter. Investor sentiment in the healthcare providers & services sector has been …

LH main company DGX mentioned

Sharemaestro market context Trend signal active 52 weeks +15.6%

04:10 29 Jul 2026

Seeking Alpha Earnings Main company 🇺🇸 United States

NeoGenomics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:NEO) 2026-07-28

This article announces that NeoGenomics, Inc. published its Q2 2026 earnings call presentation. The company reported an EPS of $0.05, beating estimates by $0.02, and revenue of $201.66M, surpassing expectations by $4.67M and representing an 11.21% year-over-year increase. The presentation is related to their …

NEO main company

Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8%

03:55 29 Jul 2026

Yahoo! Finance Canada Earnings Main company 🇺🇸 United States

IQVIA Holdings (IQV) Soars on Revenue Growth Outlook, Strong Q2

IQVIA Holdings (IQV) saw its stock jump after reporting strong second-quarter results and raising its revenue growth outlook for the full year 2026. The company grew its revenues by 8.7% to $4.37 billion in Q2, contributing to an updated full-year projection of $17.275 billion …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

03:37 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

DVA|DaVita Inc|Price:239.495|Chg%:+3.185

The article provides a comprehensive stock analysis of DaVita Inc (DVA) by TradingKey, highlighting its strong fundamentals, high growth potential, and fair valuation within the Healthcare Providers & Services industry. It notes DaVita's high institutional ownership, Warren Buffett's stake, and analysts' "Hold" rating with …

DGX mentioned

Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%

03:14 29 Jul 2026

seekingalpha.com Earnings Main company 🇺🇸 United States

NeoGenomics anticipates $802M-$806M 2026 revenue as it targets mid-20% NGS growth and adjusts pharma expectations

Earnings Call Insights: NeoGenomics (NEO) Q2 2026 MANAGEMENT VIEW * "We're raising guidance because of these results as well as the underlying clinical strength we're seeing in the back half of this year." (CEO Anthony Zook) * "Total revenue in the quarter was $201.7 …

NEO main company

Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8%

03:09 29 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

MDXH|MDxHealth SA|Price:0.400|Chg%:-0.011

This article provides a comprehensive stock analysis of MDxHealth SA (MDXH), highlighting its strong fundamentals and high growth potential despite recent weak market performance. The company is considered fairly valued within the Biotechnology & Medical Research industry and shows high institutional ownership. Analysts have …

MDXH main company

Sharemaestro market context Price below Trend Line 52 weeks -75.4% · Next-week setup negative 39.0%

02:50 29 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

Myriad Genetics Inc (MYGN) Financial Health: Profitability & Balance Sheet Analysis

Myriad Genetics Inc (MYGN) has a stable financial status and high operating efficiency, ranking 93rd out of 199 companies in the Healthcare Equipment & Supplies industry with a score of 7.30. The company reported a Q4 revenue of $200.40 million, marking a 2.30% year-over-year …

MYGN main company

Sharemaestro market context Price below Trend Line 52 weeks -49.7%

02:49 29 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

MEDP|Medpace Holdings Inc|Price:585.350|Chg%:+14.380

Medpace Holdings Inc (MEDP) closed at $585.35 on July 29, 2026, up 2.52%, with a market capitalization of $16.30 billion. The company exhibits strong fundamentals, high growth potential, and is considered fairly valued in the Biotechnology & Medical Research industry, where it ranks 65 …

MEDP main company IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +24.8% · Next-week setup positive 59.0%

02:37 29 Jul 2026

Barchart.com Earnings Main company 🇺🇸 United States

Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26

Agilent Technologies Inc. (NYSE: A) will release its third-quarter fiscal year 2026 financial results after the market closes on Wednesday, Aug. 26. The company will host a conference call on the same day at 1:30 p.m. PDT to discuss the results, which will be …

A main company

Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 44.0%

02:30 29 Jul 2026

nasdaq.com Earnings Main company 🇺🇸 United States

IQVIA (IQV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

IQVIA Holdings (IQV) reported $4.37 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 8.7%. EPS of $3.15 for the same period compares to $2.81 a year ago. The reported revenue represents a surprise of +1.63% over the Zacks …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

02:11 29 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Biodesix, Inc. Revenue Breakdown – NASDAQ:BDSX

This document provides a revenue breakdown for Biodesix, Inc. (NASDAQ: BDSX), accessible through TradingView. It offers an overview of the company's financial information, including statements, statistics, dividends, earnings, and segment performance by source and country. The information is sourced from ICE Data Services, FactSet, …

BDSX main company

Sharemaestro market context Trend signal active 52 weeks +164.7% · Next-week setup negative 43.8%

01:37 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

Amgen Inc Stock (AMGN) Moved Up by 4.02% on Jul 28: What Signal Does It Send?

Amgen Inc (AMGN) saw a 4.02% increase in its stock price, driven by strong second-quarter earnings that surpassed estimates and positive clinical data for its obesity drug MariTide. Technical indicators suggest a buy signal, though clinical safety concerns about MariTide and high pipeline dependency …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

01:10 29 Jul 2026

TradingKey Analyst action Provider-linked mention 🇺🇸 United States

IBIO|iBio Inc|Price:1.389|Chg%:-0.001

This article provides a comprehensive stock analysis of iBio Inc (IBIO) by TradingKey, highlighting its healthy fundamentals, high growth potential, and relatively fair valuation within the Biotechnology & Medical Research industry. Despite recent weak stock market performance, the company exhibits strong fundamentals, very high …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

01:10 29 Jul 2026

TradingKey Analyst action Provider-linked mention 🇺🇸 United States

IKT|Inhibikase Therapeutics Inc|Price:2.217|Chg%:-0.093

Inhibikase Therapeutics Inc (IKT) shows strong fundamentals and high growth potential, despite recent technical trends not fully supporting its performance. The company is considered fairly valued and has high institutional ownership. Analysts have given it a "Buy" rating with a target price indicating significant …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

00:42 29 Jul 2026

Moomoo Deals and strategy Main company 🇺🇸 United States

ICON Shares Rise on Anthropic Collaboration to Bring AI Across Clinical Trials

ICON plc (ICLR) saw its shares rise following an announcement of a collaboration with Anthropic, an AI safety and research company. This partnership aims to integrate Anthropic's generative AI, Claude, into ICON's clinical trial operations, enhancing efficiency, improving data analysis, and accelerating patient outcomes. …

ICLR main company

Sharemaestro market context Trend signal active 52 weeks -7.2%

00:36 29 Jul 2026

scanx.trade Earnings Main company 🇺🇸 United States

Agilent Technologies Q3 Results: Earnings call set for Aug 26

Agilent Technologies Inc. will report its third-quarter fiscal year 2026 financial results after market close on August 26th. A conference call will follow at 1:30 p.m. PDT to discuss the company's performance and operational trends. In fiscal year 2025, Agilent Technologies generated $6.95 billion …

A main company

Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 44.0%

00:33 29 Jul 2026

GuruFocus Earnings Main company 🇺🇸 United States

Revvity Inc (RVTY) Stock Up 3.2% and Still Undervalued -- GF Sco

Revvity Inc (RVTY) shares rose 3.2% to $111.51, reflecting a 15.5% year-to-date gain, yet the stock is considered 7.5% undervalued with a GF Value of $120.57. Despite an attractive valuation rank of 10/10, its growth rank is low at 3/10, and the P/E ratio …

RVTY main company

Sharemaestro market context Trend signal active 52 weeks +24.4%

00:10 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

GLMD|Galmed Pharmaceuticals Ltd|Price:0.543|Chg%:+0.009

This article provides a comprehensive stock analysis of Galmed Pharmaceuticals Ltd (GLMD), highlighting its stable fundamentals, high growth potential, and fair valuation compared to its industry peers. The company's main focus is on developing Aramchol for treating non-alcoholic steatohepatitis (NASH). Despite average recent stock …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

00:10 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

GERN|Geron Corp|Price:1.415|Chg%:-0.035

This article provides a comprehensive stock analysis of Geron Corp (GERN) by TradingKey, highlighting its stable fundamentals, high growth potential, and fair valuation within the Biotechnology & Medical Research industry. Despite positive analyst ratings and recent market outperformance, technical indicators suggest the stock is …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

23:42 28 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Illumina, Inc. Revenue Breakdown – LSX:927079

This article provides a revenue breakdown for Illumina, Inc. (LSX:927079), detailing its performance in the last fiscal year. The company generated 3.70 billion EUR, with its Core Illumina - Consumables segment being the top contributor at 2.75 billion EUR. Geographically, the United States was …

ILMN main company

Sharemaestro market context Trend signal active 52 weeks +87.5%

23:40 28 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview

Fulgent Genetics Inc (FLGT) is projected to report a loss of 46 cents per share in its upcoming earnings announcement. This preview indicates the anticipated financial performance for the company, suggesting a negative earnings per share.

FLGT main company

Sharemaestro market context Price above Trend Line 52 weeks -14.7% · Next-week setup negative 42.1%

23:40 28 Jul 2026

Pluang Earnings Main company 🇺🇸 United States

Veracyte to present at two major healthcare investor conferences in August and September 2026

Veracyte, a cancer diagnostics company, announced its participation in two key healthcare investor conferences: the Canaccord Genuity Growth Conference in August and the Morgan Stanley Global Healthcare Conference in September 2026. The company will conduct fireside chats at both events to discuss its diagnostic …

VCYT main company

Sharemaestro market context Trend signal active 52 weeks +33.1%

23:38 28 Jul 2026

TradingView Analyst action Main company 🇺🇸 United States

IQVIA Holdings, Inc. Stock 12‑Month Price Target Raised to $232.22, Implies 9% Upside

Analysts have raised the average 12-month price target for IQVIA Holdings, Inc. (IQV) stock to $232.22, up from $230. This new target suggests a potential upside of approximately 9% based on the recent closing price. The consensus rating for IQV remains a "Buy" among …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

23:10 28 Jul 2026

TradingKey Analyst action Provider-linked mention 🇺🇸 United States

FMS|Fresenius Medical Care AG|Price:24.880|Chg%:+0.130

This article provides a comprehensive stock analysis of Fresenius Medical Care AG (FMS), highlighting its relatively healthy fundamentals, high growth potential, and fair valuation. It notes high institutional ownership and a medium-term upward trend prediction for the stock price, despite technicals not fully supporting …

DGX mentioned LH mentioned

Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%

23:06 28 Jul 2026

nasdaq.com Earnings Main company 🇺🇸 United States

Why Opko Health Stock Surged by 33% on Tuesday

Key Points Investors were also cheered by a substantial narrowing of the company's net loss. Ditto for the raised full-year revenue guidance.10 stocks we like better than Opko Health › Opko Health(NASDAQ: OPK) was one of the healthier stocks on the exchange Tuesday. Its …

OPK main company

Sharemaestro market context Trend signal active 52 weeks -2.1%

22:41 28 Jul 2026

Stock Titan Deals and strategy Main company 🇺🇸 United States

BlackRock (GRAL holder) discloses 7.9% GRAIL, Inc. stake in 13G/A

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.9% passive ownership stake in GRAIL, Inc. (GRAL). This ownership amounts to 3,376,085 shares of GRAIL common stock, with BlackRock holding sole voting power over 3,312,474 shares and sole dispositive power over all 3,376,085 …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%

22:41 28 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

NeoGenomics (NASDAQ:NEO) Posts Earnings Results, Beats Expectations By $0.02 EPS

NeoGenomics (NASDAQ:NEO) reported quarterly earnings that surpassed analyst expectations, with an EPS of $0.05 against an estimated $0.03, and revenue of $201.66 million, exceeding the $196.93 million estimate. Despite the positive earnings surprise, the company posted a negative net margin and return on equity. …

NEO main company

Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8%

22:41 28 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

Earnings call transcript: NeoGenomics tops Q2 2026 estimates and lifts outlook

NeoGenomics Inc. reported strong second-quarter 2026 earnings, surpassing Wall Street expectations for both profit and sales, driven by robust clinical and next-generation sequencing (NGS) business growth. The company raised its full-year 2026 revenue and adjusted EBITDA guidance, despite continued weakness in its non-clinical pharma …

NEO main company

Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8%

22:12 28 Jul 2026

Kalkine Media Earnings Main company 🇺🇸 United States

Fulgent Genetics CSO Gao Hanlin Executes Tax-Related Sale of 1,645 Shares at $19.67 on July 26, 2026

Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, Inc. (NASDAQ: FLGT), sold 1,645 common shares at $19.67 each on July 26, 2026, to cover tax obligations. Following this transaction, Hanlin still directly owns 988,729 common shares in the genomics testing company. The sale was …

FLGT main company

Sharemaestro market context Price above Trend Line 52 weeks -14.7% · Next-week setup negative 42.1%

21:41 28 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

BlackRock (NYSE: BLK) discloses 5.5% beneficial ownership in GeneDx (WGS)

BlackRock, Inc. has filed a Schedule 13G disclosing a 5.5% beneficial ownership in GeneDx Holdings Corp. (WGS). The filing indicates BlackRock owns 1,622,518 shares of Class A stock, with sole voting power over 1,588,670 shares and sole dispositive power over all 1,622,518 shares. No …

WGS main company

Sharemaestro market context Price above Trend Line 52 weeks -39.3%

21:41 28 Jul 2026

AlphaStreet Earnings Main company 🇺🇸 United States

NeoGenomics Releases Q2 2026 Financial Results

NeoGenomics, Inc. reported strong Q2 2026 financial results, with adjusted EPS of $0.05, significantly beating analyst estimates, and revenue of $201.7M, surpassing consensus. The company saw an 11.2% increase in revenue year-over-year, primarily driven by its clinical services segment. Management provided full-year adjusted EPS …

NEO main company

Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8%